A hidden strategy: How SARS-CoV-2 uses fibrinogen to evade the immune system
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
Computational drug discovery: Exploring natural products targeting SARS-CoV-2
The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
AI learns to 'speak' genetic 'dialect' for future SARS-CoV-2 mutation prediction
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
SARS-CoV-2 Virus Is Still Circulating! Experts Warn – Here’s How To Boost Your Immunity To Stay Safe
Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...
Fred Hutch12d
COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days
The authors sequenced 3,606 viral genomes from unique COVID events at UW and compared their sequences to publicly accessible SARS-CoV-2 genomes from Washington in an online database. They first wanted ...
News-Medical.Net on MSN12d
Natural compounds identified as potential inhibitors of SARS-CoV-2 spike protein
Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...
Rheumatology Advisor5d
COVID-19 mRNA-1273 Vaccine Highly Protective in Pediatric Patients After 2 Doses
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
Physician's Weekly14d
Repeated N-Antigen Antibody Monitoring for Assessing SARS-CoV-2 Exposure
CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...